Invesco’s BioLife Solutions BLFS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $63.3M | Sell |
2,240,423
-108,109
| -5% | -$2.53M | 0.01% | 1046 |
|
|
2026
Q1 | $44.8M | Sell |
2,348,532
-1,583,659
| -40% | -$35M | ﹤0.01% | 1113 |
|
|
2025
Q4 | $95.1M | Buy |
3,932,191
+332,747
| +9% | +$8.71M | 0.01% | 845 |
|
|
2025
Q3 | $91.8M | Buy |
3,599,444
+18,666
| +0.5% | +$443K | 0.01% | 860 |
|
|
2025
Q2 | $77.1M | Buy |
3,580,778
+29,724
| +0.8% | +$670K | 0.01% | 895 |
|
|
2025
Q1 | $81.1M | Buy |
3,551,054
+311,585
| +10% | +$8.21M | 0.02% | 861 |
|
|
2024
Q4 | $84.1M | Buy |
3,239,469
+36,176
| +1% | +$900K | 0.02% | 859 |
|
|
2024
Q3 | $80.2M | Sell |
3,203,293
-116,838
| -4% | -$2.76M | 0.02% | 869 |
|
|
2024
Q2 | $71.2M | Buy |
3,320,131
+2,044,714
| +160% | +$39.7M | 0.02% | 879 |
|
|
2024
Q1 | $23.7M | Buy |
1,275,417
+91,858
| +8% | +$1.61M | 0.01% | 1363 |
|
|
2023
Q4 | $19.2M | Buy |
1,183,559
+131,494
| +12% | +$1.68M | ﹤0.01% | 1428 |
|
|
2023
Q3 | $14.5M | Buy |
1,052,065
+64,475
| +7% | +$1.02M | ﹤0.01% | 1520 |
|
|
2023
Q2 | $21.8M | Buy |
987,590
+179,950
| +22% | +$3.79M | 0.01% | 1320 |
|
|
2023
Q1 | $17.6M | Buy |
807,640
+8,484
| +1% | +$191K | ﹤0.01% | 1415 |
|
|
2022
Q4 | $14.5M | Buy |
799,156
+26,548
| +3% | +$548K | ﹤0.01% | 1564 |
|
|
2022
Q3 | $17.6M | Buy |
772,608
+16,687
| +2% | +$357K | 0.01% | 1407 |
|
|
2022
Q2 | $10.4M | Sell |
755,921
-4,568
| -0.6% | -$67K | ﹤0.01% | 1821 |
|
|
2022
Q1 | $17.3M | Sell |
760,489
-9,247
| -1% | -$243K | ﹤0.01% | 1607 |
|
|
2021
Q4 | $28.7M | Buy |
769,736
+163,176
| +27% | +$7M | 0.01% | 1319 |
|
|
2021
Q3 | $25.7M | Buy |
606,560
+112,099
| +23% | +$5.4M | 0.01% | 1407 |
|
|
2021
Q2 | $22M | Buy |
494,461
+74,816
| +18% | +$2.64M | 0.01% | 1550 |
|
|
2021
Q1 | $15.1M | Buy |
419,645
+278,914
| +198% | +$11M | ﹤0.01% | 1714 |
|
|
2020
Q4 | $5.61M | Sell |
140,731
-11,280
| -7% | -$385K | ﹤0.01% | 2121 |
|
|
2020
Q3 | $4.4M | Buy |
+152,011
| New | +$3.28M | ﹤0.01% | 2070 |
|
|
2019
Q4 | – | Sell |
-10,338
| Closed | -$172K | – | 3656 |
|
|
2019
Q3 | $172K | Sell |
10,338
-70,981
| -87% | -$1.33M | ﹤0.01% | 3573 |
|
|
2019
Q2 | $1.38M | Buy |
81,319
+3,669
| +5% | +$64K | ﹤0.01% | 2887 |
|
|
2019
Q1 | $1.39M | Buy |
77,650
+51,781
| +200% | +$824K | ﹤0.01% | 2836 |
|
|
2018
Q4 | $311K | Sell |
25,869
-7,648
| -23% | -$91.3K | ﹤0.01% | 3457 |
|
|
2018
Q3 | $587K | Buy |
33,517
+6,609
| +25% | +$131K | ﹤0.01% | 3364 |
|
|
2018
Q2 | $307K | Buy |
+26,908
| New | +$245K | ﹤0.01% | 3589 |
|
Other funds holding BLFS
CC
FAM
Invesco's BLFS Position: Q2 2026 in Review
Invesco reduced its BioLife Solutions (BLFS) stake by 4.6% in Q2 2026, selling an estimated $2.53M and leaving 2,240,423 shares worth $63.3M. The position accounts for 0.01% of the portfolio, ranked #1046.
Invesco first reported a position in BLFS in Q2 2018 and has held it in 30 quarters since. The position peaked at $95.1M in Q4 2025. 217 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.
- Invesco held 2,240,423 shares of BioLife Solutions worth $63.3M as of Q2 2026.
- Invesco sold 108,109 BioLife Solutions shares in Q2 2026, an estimated $2.53M.
- BioLife Solutions made up 0.01% of Invesco's portfolio in Q2 2026, its #1046 holding.
- Invesco first reported a position in BioLife Solutions in Q2 2018 and has held it in 30 quarters since.
- Invesco's BioLife Solutions position peaked at $95.1M in Q4 2025.
- 217 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.